E. Ohman J:or Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.3M Buy
65,270
+37,773
+137% +$38.6M 1.82% 9
2026
Q1
$25.3M Buy
27,497
+171
+0.6% +$173K 0.67% 37
2025
Q4
$29.4M Sell
27,326
-14,254
-34% -$13.6M 0.68% 36
2025
Q3
$31.7M Buy
41,580
+1,547
+4% +$1.15M 0.75% 32
2025
Q2
$31.2M Sell
40,033
-53,163
-57% -$41.3M 0.77% 33
2025
Q1
$77M Buy
93,196
+2,942
+3% +$2.45M 2.05% 9
2024
Q4
$69.7M Buy
90,254
+17,259
+24% +$14.3M 1.62% 12
2024
Q3
$64.7M Buy
72,995
+6,915
+10% +$6.22M 1.6% 12
2024
Q2
$59.8M Buy
66,080
+3,890
+6% +$3.11M 1.48% 11
2024
Q1
$48.4M Buy
62,190
+22,790
+58% +$16.2M 1.23% 19
2023
Q4
$23M Buy
39,400
+16,704
+74% +$9.75M 0.84% 36
2023
Q3
$12.2M Buy
22,696
+8,600
+61% +$4.43M 0.46% 46
2023
Q2
$6.61M Sell
14,096
-5,000
-26% -$2.1M 0.24% 62
2023
Q1
$6.56M Buy
19,096
+3,000
+19% +$1.01M 0.26% 63
2022
Q4
$5.89M Hold
16,096
0.26% 64
2022
Q3
$5.2M Buy
+16,096
New +$5.1M 0.24% 69
2022
Q1
Sell
-39,800
Closed -$11M 443
2021
Q4
$11M Buy
+39,800
New +$10.1M 0.32% 57
2021
Q3
Sell
-20,600
Closed -$4.73M 470
2021
Q2
$4.73M Buy
+20,600
New +$4.14M 0.15% 96
2019
Q4
Sell
-22,760
Closed -$2.55M 455
2019
Q3
$2.55M Buy
22,760
+1,200
+6% +$134K 0.16% 79
2019
Q2
$2.39M Sell
21,560
-2,500
-10% -$294K 0.16% 79
2019
Q1
$3.12M Sell
24,060
-193,427
-89% -$23.5M 0.21% 69
2018
Q4
$25.2M Sell
217,487
-30,629
-12% -$3.42M 1.83% 12
2018
Q3
$26.6M Sell
248,116
-22,921
-8% -$2.29M 1.72% 15
2018
Q2
$23.1M Buy
271,037
+56,514
+26% +$4.64M 1.65% 15
2018
Q1
$16.6M Buy
214,523
+8,868
+4% +$714K 1.33% 20
2017
Q4
$17.4M Buy
205,655
+37,523
+22% +$3.19M 1.41% 16
2017
Q3
$14.4M Buy
168,132
+141,932
+542% +$11.6M 1.28% 22
2017
Q2
$2.16M Hold
26,200
0.22% 78
2017
Q1
$2.2M Buy
26,200
+3,900
+17% +$312K 0.27% 76
2016
Q4
$1.64M Buy
22,300
+1,200
+6% +$89.4K 0.23% 88
2016
Q3
$1.69M Buy
21,100
+1,500
+8% +$120K 0.25% 80
2016
Q2
$1.54M Buy
19,600
+2,100
+12% +$158K 0.26% 76
2016
Q1
$1.26M Sell
17,500
-1,600
-8% -$121K 0.23% 82
2015
Q4
$1.61M Hold
19,100
0.28% 75
2015
Q3
$1.6M Sell
19,100
-1,900
-9% -$160K 0.43% 55
2015
Q2
$1.75M Sell
21,000
-1,300
-6% -$99.1K 0.41% 56
2015
Q1
$1.62M Hold
22,300
0.38% 61
2014
Q4
$1.55M Hold
22,300
0.37% 62
2014
Q3
$1.45M Hold
22,300
0.35% 61
2014
Q2
$1.39M Hold
22,300
0.34% 68
2014
Q1
$1.31M Sell
22,300
-3,200
-13% -$179K 0.33% 69
2013
Q4
$1.3M Sell
25,500
-1,300
-5% -$65.1K 0.31% 72
2013
Q3
$1.35M Buy
26,800
+2,500
+10% +$131K 0.34% 67
2013
Q2
$1.19M Buy
+24,300
New +$1.32M 0.33% 66

Other funds holding LLY

E. Ohman J:or Asset Management's LLY Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Eli Lilly (LLY) stake by 137% in Q2 2026, buying an estimated $38.6M and bringing the position to 65,270 shares worth $78.3M. The position accounts for 1.82% of the portfolio, ranked #9.

E. Ohman J:or Asset Management first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • E. Ohman J:or Asset Management held 65,270 shares of Eli Lilly worth $78.3M as of Q2 2026.
  • E. Ohman J:or Asset Management bought 37,773 Eli Lilly shares in Q2 2026, an estimated $38.6M.
  • Eli Lilly made up 1.82% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #9 holding.
  • E. Ohman J:or Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.